EDWIN L. FERREN

Plain English
This study looked at how cholic acid affects patients with Smith-Lemli-Opitz Syndrome (SLOS), a genetic disorder that hampers cholesterol production and causes various health issues. Eight young patients (ages 1 to 20) were given cholic acid alongside dietary cholesterol, and most saw improvements in their cholesterol levels, growth, and even behavior, with reports of better social interactions and communication skills. This is important because it shows that cholic acid can help manage some symptoms of SLOS and improve quality of life with minimal side effects. Who this helps: This benefits patients with SLOS and their families.

Plain English
This study looked at a specific liver disorder called Progressive Familial Intrahepatic Cholestasis type 2 (PFIC-2), which mainly affects infants and children. It found a case where a child with PFIC-2 had severe issues like easy bruising and bleeding, along with symptoms such as jaundice and anemia. Understanding these symptoms in relation to PFIC-2 is important because it helps doctors recognize and treat this serious condition more effectively. Who this helps: Children with PFIC-2 and their doctors.

Plain English
This study looked at how specific ratios of amino acids in the blood can help identify serious genetic disorders that lead to high levels of lactic acid in newborns. Researchers found that using the ratios of alanine to leucine and proline to leucine as screening tools could effectively flag cases of these disorders, successfully identifying several newborns with rare mutations. This knowledge is crucial because early detection can lead to timely treatment, improving outcomes for affected infants. Who this helps: This helps newborns at risk for mitochondrial disorders and their families.